top of page


April - Cancer Awareness Month

Facilitating donations on behalf of Presidential Exteriors LLC in support of the John Cleland Testis Cancer Fellowship

Dr. Larry Einhorn

Lawrence Einhorn, MD, has been on the IU School of Medicine Department of Medicine faculty since 1973. His field of expertise includes clinical trials and supportive care, with focus in the areas of lung and testicular cancers. Dr. Einhorn has also been involved in the clinical development of new drug therapies. Studies chaired by Dr. Einhorn at IU School of Medicine in the area of testicular cancer led to the FDA approval of cisplatin, etoposide and ifosfamide. In addition, his groups conducted the pivotal studies that led to the approval of both gemcitabine and pemetrexed in non-small cell lung cancer.

John Cleland

John was a 47-year cancer survivor, of which he was immensely proud. He was the first person to be successfully treated for testicular cancer with cisplatin, now one of the primary treatments for the disease. After recovering from cancer, he strived to exude a Carpe Diem attitude for the rest of his life.

Testis Cancer Fellowship

The John Cleland Testis Cancer Fellowship Fund was created in memory of John Cleland, with the goal of promoting ongoing training in testis cancer research among fellow trainees

bottom of page